NASDAQ | ETF
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 7.89% |
| PFE | Pfizer Inc | Healthcare | Drug Manufacturers - General | 7.32% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 6.94% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 6.93% |
| BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 6.76% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 3.77% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 3.72% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 3.68% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 3.61% |
| UTHR | United Therapeutics Corporation | Healthcare | Biotechnology | 3.59% |
| VTRS | Viatris Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.58% |
| CAH | Cardinal Health Inc | Healthcare | Medical Distribution | 3.53% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 3.5% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 3.47% |
| JAZZ | Jazz Pharmaceuticals PLC | Healthcare | Biotechnology | 3.09% |
| ZTS | Zoetis Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.05% |
| OGN | Organon & Co | Healthcare | Drug Manufacturers - General | 2.81% |
| CRL | Charles River Laboratories | Healthcare | Diagnostics & Research | 2.06% |
| PRGO | Perrigo Company PLC | Healthcare | Drug Manufacturers - Specialty & Generic | 1.56% |
| MEDP | Medpace Holdings Inc | Healthcare | Diagnostics & Research | 1.52% |
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index. The index is designed to provide exposure to U.S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and ranking. It is non-diversified.